BEE VECTORING TECH. INTL. WKN: A14WDZ ISIN: CA0765881028 Kürzel: 1UR1 Forum: Aktien Thema: Hauptdiskussion

KE oder?

Mississauga, ON Canada and Sacramento, CA USA (November 24, 2020) – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE) today announced it will intensify its near-term direction to accelerate revenue growth in 2021 and focus on sales and marketing in key regions for the upcoming growing season. The Company’s long-term strategy and objectives remain consistent with previous guidance. “Over the past several years we demonstrated the significant benefits that our natural precision agriculture system delivers to farmers. Since we entered the commercialization phase of our business after receiving EPA approval in August 2019, we have gained significant traction throughout the United States, which we have been able to demonstrate through increasing acreage adoption by farmers of our technology for the upcoming growing season compared to the previous season,” said Ashish Malik, CEO of Bee Vectoring Technologies. “We have now entered a new and very exciting phase in the evolution of our business, where we see a very large and imminent opportunity in front of the Company allowing us to further accelerate our sales and marketing efforts to capitalize and establish our footprint in the US agricultural market.” “In order to support this new phase of growth and increase shareholder value, management, insiders and consultants of BVT have unanimously decided to exchange on average more than 50% of their compensation for equity in the company, allowing our team to allocate every dollar possible towards this initiative,” said Michael Collinson, Chairman of the Board of Directors for Bee Vectoring Technologies. “With this re-allocation of capital, we are moving to hire additional salespeople and invest even more heavily into sales and marketing activities in specific US regions where we are confident that our efforts will result in successful sales execution and delivery of our short-term objectives.” The following objectives will be the Company’s priority in 2021: Focus on US revenue growth and secure a minimum of CAD$1million in revenue; Hire additional salespeople to serve key US markets (e.g. Pacific Northwest, California, Midwest); Accelerate marketing to raise awareness of BVT in target markets; Initiate grower trials in California, the biggest market opportunity for BVT in North America,  to build demand and lay the groundwork for possible revenue in 2021 in anticipation of imminent regulatory approval;   Finalize business operations for Switzerland including partnerships, plus increase grower trials in anticipation of near-term regulatory approval;   Initiate grower trials in Mexico with influential players, where the Company expects to submit for regulatory approval in the coming months, to facilitate rapid commercial adoption once approval is achieved.   “Achieving these short-term objectives will cement BVT as a revenue growth generating company,” continued Mr. Malik. “They will create value in the near term, which will in turn allow the company to work on longer term objectives around market expansion and product line extensions.” The Company has issued 2,580,000 restricted share units of the Company (“RSUs“) under the Company’s shareholder approved restricted share unit plan (the “RSU Plan“) to the Company’s management, insiders and consultants (collectively, “Holders”). The RSUs will vest upon successful completion of pre-determined milestones (as determined by the board of directors and agreed upon by the Holders) being met and shall entitle the Holders to acquire one common share (a “Share”) of the Company underlying each such RSU by delivering a notice of acquisition to the Company in accordance with the RSU Plan. In accordance with the RSU Plan, the RSUs were priced at $0.29 based on the closing price of the Shares on the Canadian Securities Exchange (CSE) on November 23, 2020. The Company has also issued 275,000 stock options (“Options”) to two insiders of the Company. The Options vest immediately and are valid for a period of five years from issuance with an exercise price of $0.29. All Securities will be subject to a statutory four month hold period from the date of issuance.

http://www.beevt.com/press-releases/11242020-bee-vectoring-technologies-enters-new-phase-to-accelerate-revenue-growth-in-2021

Keine Sorge, der sinkt auch wieder 😝

Was ist denn los? Der Kurs steigt 😳. Gibt es News?

Wurde scho gepostet

Artikel ist schon älter...

Sorry ich meinte in der Schweiz und ob es nach Europa kommt bzw. Zugelassen wird muss man abwarten. Ps. Schweiz gehört ja nicht zur EU🥴

Moin zusammen... die Resultate hören sich erstmal garnicht so schlecht an und das Registrierungsverfahren Soll auch bald beendet werden und in Europa/ Schweiz zugelassen werden.

http://www.beevt.com/industry-news/articles/10022020-hummeln-als-pflanzenschutzer

Das stimmt Selllow, Ich mache mir auch erst Gedanken über einen Nachkauf entweder Bei einem sturz auf 0,10c oder Bei einer zu erkennenden Charttechnischen trendwende.

Also ich mach erst wieder nachkäufe wenn der laden richtig läuft. Ich denke wenn alles läuft wie geplant ist es egal ob man für 0,30 oder 0,20 eingestiegen ist. Das risiko eines totalausfalls bleibt leider weiterhin..

Warum haben die jetzt Kohle zum sponsern über!!! 😂

https://m.facebook.com/story.php?story_fbid=3440945882650190&id=897121250366012

Ich würde damit noch ein wenig warten. Vielleicht kratzen wir nochmal die 0.16 oder gar die 0.15 an. Mein EK lag auch mal im 0.3er Bereich und inzwischen hab ich ihn auf 0.206 gedrückt. Hier ist auch erstmal Schluss bis zum nächsten Jahr und die damit verbundenen Perspektiven.

Mein EK ist 0.358 - Versuch ihn noch auf 0.260 runter zu schrauben :) Das mein Ziel bis 2021